Benicia, CA, United States of America

Kathelyn S Steimer



Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 88(Granted Patents)


Location History:

  • El Cerrito, CA (US) (2002)
  • Benicia, CA (US) (1997 - 2009)

Company Filing History:


Years Active: 1997-2009

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kathelyn S. Steimer

Introduction

Kathelyn S. Steimer is a prominent inventor based in Benicia, California, known for her significant contributions to the field of biotechnology. With a total of seven patents to her name, she has made remarkable advancements in the diagnosis and treatment of retroviral infections, particularly HIV.

Latest Patents

Among her latest patents are groundbreaking inventions such as a purified pol DNA and a recombinant DNA construct for the expression of HIV pol polypeptide sequences. These inventions include a cell containing such constructs, which provide polynucleotide sequences for diagnosing the presence of retroviral infections in human hosts associated with lymphadenopathy syndrome and acquired immune deficiency syndrome. Her work emphasizes the expression of polypeptides and the use of these polypeptides to prepare antibodies, which can serve as diagnostic reagents or therapeutic agents, including vaccines and passive immunization. The sequences she developed enable the detection of viral infectious agents linked to these syndromes and facilitate the expression of antigenic polypeptides.

Career Highlights

Throughout her career, Kathelyn has worked with notable companies such as Novartis Vaccines & Diagnostics and Chiron Corporation. Her experience in these organizations has allowed her to contribute to significant advancements in vaccine development and diagnostics.

Collaborations

Kathelyn has collaborated with esteemed colleagues, including Paul A. Luciw and Dino Dina, further enhancing her research and innovation in the field.

Conclusion

Kathelyn S. Steimer's innovative work in biotechnology has made a lasting impact on the diagnosis and treatment of retroviral infections. Her patents and collaborations reflect her dedication to advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…